Trademarkia Logo

Canada

C$
GLOPERBA
FORMALIZED

on 19 Jun 2024

Last Applicant/ Owned by

RXOMEG THERAPEUTICS LLC

400 TradeCenter, Suite 5900Woburn MA 01801

US

Serial Number

2333769 filed on 2th Apr 2024

Correspondent Address

KELLY LYNNE MOFFATT

(OSLER, HOSKIN & HARCOURT LLP)BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

CA

M5X1B8

GLOPERBA

Trademark usage description

colchicine based pharmaceutical preparations for the prevention of gout flares, recurrent pericarditis, familial mediterranean fever (fmf), behcet's d Read More

Classification Information


Class [005]
Colchicine based pharmaceutical preparations for the prevention of gout flares, recurrent pericarditis, familial Mediterranean fever (FMF), Behcet's disease and long-term atrial fibrillation; colchicine based pharmaceutical preparations for the treatment of acute gout flares, acute pericarditis, on-going Behcet's disease, familial Mediterranean fever (FMF), and acute atrial fibrillation attack.


Classification kind code

12

Mark Details


Serial Number

2333769

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 19th Jul 2024
Agent Changed
Submitted for opposition 257
on 20th Jun 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Jun 2024
Created
Submitted for opposition 31
on 19th Jun 2024
Formalized
Submitted for opposition 228
on 2th Apr 2024
International Registration
Submitted for opposition 30
on 2th Apr 2024
Filed